Cytokeratin 13 Antibody

Skip to product information
1 of 3

Selleck Chemicals

SKU:F2188-20UL

Regular price €199,00 EUR
Regular price Sale price €199,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Cytokeratin 13 (CK13) is a 54 kDa type I acidic cytokeratin encoded by the KRT13 gene on chromosome 17q21. It primarily forms heterodimers with type II cytokeratin CK4 and is found in the suprabasal layers of non-cornified stratified squamous epithelium, such as in the oral cavity, esophagus, and urothelium. Depending on the literature source, KRT13 may also be discussed as Cytokeratin 13 and Keratin.

Reported cellular context includes intermediate filament and keratin, which can matter when signal is compared across treatments or changing cell states. Following KRT13 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

KRT13 is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans intermediate filament and keratin, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between intermediate filament and keratin across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for KRT13. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in KRT13 reflect biology rather than handling. When interpreting KRT13, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep KRT13 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
KRT13
Research Area:
Cancer • Cell Signaling
Application:
FCM • IF • IHC • WB
Reactivity:
Human
Specificity:
Cytokeratin 13 Antibody [L12L19] detects endogenous levels of total Cytokeratin 13 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
L12L19
UniProt:
P13646
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.